Herpes zoster in Germany: quantifying the burden of disease.

Ultsch, Bernhard; Siedler, Anette; Rieck, Thorsten; Reinhold, Thomas; Krause, Gerard; Wichmann, Ole

Name:

Ultsch et al_final.pdf

Size:

311.1Kb

Format:

PDF

Description:

Open Access publication

Download

Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item. When enough users have cast their vote on this item, the average rating will also be shown.

Star rating

Your vote was cast
Thank you for your feedback

Authors

Ultsch, Bernhard
Siedler, Anette
Rieck, Thorsten
Reinhold, Thomas
Krause, Gerard

Wichmann, Ole

Issue Date

2011

Metadata

Show full item record

Abstract

Herpes zoster (HZ) is caused by a reactivation of the varicella-zoster-virus (VZV) and mainly affects individuals aged≥50 years. Vaccines have been licensed or are under development that can protect against HZ and its main complication postherpetic neuralgia (PHN). In Germany, the burden of disease caused by HZ is not well known. To support the decision making process related to a potential vaccination recommendation, we estimated annual HZ disease burden in people aged≥50 years in Germany by utilizing various data sources.

Citation

Herpes zoster in Germany: quantifying the burden of disease. 2011, 11:173 BMC Infect. Dis.

Affiliation

Helmholtz Centre for infection research, Inhoffenstr. 7, 38124 Braunschweig, Germany.

Type

Article

Language

ISSN

1471-2334

Collections

publications of the research group of epidemiology (EPID)

The following license files are associated with this item: